Farmakologian ja toksikologian laitos
Department of Pharmacology and Toxicology

Julkaisut 2006
Publications 2006

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Annola K et al. Mitä lääkkeiden haittavaikutuksista kysytään? Kuopion Lääkeinformaatiokeskukseen tulleiden puhelujen sisältö.
2 Boghossian S et al. Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones.
3 Bosnyakova D et al. Time-frequency analysis of spike-wave discharges using a modified wavelet transform.
4 El-Nezami HS et al. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China.
5 El-Tahtawy A et al. Population pharmacokinetics of oxycodone in children 6 months to 7 years old.
6 Fallarero A et al. Effects of the aqueous extract of Bryothamnion triquetrum on chemical hypoxia and aglycemia-induced damage in GT1-7 mouse hypothalamic immortalized cells.
7 Gratz S et al. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B1 in rats.
8 Haapalinna A. The effects of Atipamezole on Brain Neurochemistry and Behaviour in Laboratory Rodents. Possible Implications for the Treatment of Neurodegenerative Diseases with an Alpha2-adrenoceptor Antagonist.
9 Hartikainen S et al. Serotoniinisyndrooma: iäkästä miestä hikoiluttaa, ahdistaa ja tärisyttää.
10 Heikkilä T et al. Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies.
11 Helin-Salmivaara A et al. Tanskasta mallia yleislääkärin työn kehittämiseen.
12 Helin-Salmivaara A et al. Mitä nyt sydänpotilaalle kipulääkkeeksi?
13 Helin-Salmivaara A et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.
14 Idänpään-Heikkilä JE, Huupponen R. Lääketutkimuksen eettiset ohjeet ja avoimuuden parantaminen.
15 Jarho EM et al. An introduction of a pyridine group into the structure of prolyl oligopeptidase inhibitors.
16 Karppanen H, Mervaala E. Sodium intake and hypertension.
17 Kemppainen T et al. Acetaminophen is highly effective in pain treatment after endoscopic sinus surgery.
18 Klaukka T et al. Ulkuslääkitys kriittisessä tarkastelussa Ruotsissa.
19 Kokki H. Lasten sedaatio ja kivunhoito.
20 Kokki H et al. Interpleural bupivacaine and intravenous oxycodone for pain treatment after thoracotomy in children.
21 Kokki H et al. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children.
22 Kumpulainen H et al. Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure.
23 Lahtinen P et al. Pain after cardiac surgery. A prospective cohort study of 1-year incidence and intensity.
24 Laisalmi M et al. Effects of cigarette smoking on serum fluoride concentrations and renal function integrity after 1 MAC-h sevoflurane anaesthesia.
25 Laitinen K. Kuinka hallita interaktioita?
26 Laitinen K. Onko statiineista hyötyä?
27 Lappalainen K et al. Sieni-infektion paikallinen mikonatsolihoito ei sovellu varfariinia saavalle.
28 Lappalainen K et al. Sieni-infektion paikallinen mikonatsolihoito ei sovellu varfariinia saavalle.
29 Loikkanen J et al. Effect of glutamate and extracellular calcium on uptake of inorganic lead (Pb2+) in immortalized mouse hypothalamic GT1-7 neuronal cells.
30 MacDonald E, Saarti J. Blues for the lecture theatre - the pharmacology songbook.
31 MacDonald E, Saarti J. Blues for the lecture theatre - the pharmacology songbook.
32 MacDonald E, Saarti J. Beta-blocker blues: pharmacology with a blues beat.
33 Mannila A et al. Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young children.
34 Mervaala E. Aspiriiniresistenssi.
35 Midzyanovskaya IS et al. The brain 5HTergic response to an acute sound stress in rats with generalized (absence and audiogenic) epilepsy.
36 Ojala R, Laitinen K. Milloin lääkkeen haittavaikutuksesta pitää ilmoittaa Lääkelaitoksen haittavaikutusrekisteriin?
37 Pasanen M. Geeniterapia.
38 Pelkonen O et al. Placental toxicity of organophosphate and carbamate pesticides.
39 Puttonen KA et al. A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.
40 Raitio KH et al. Synthesis and in vitro evaluation of novel 2-oxo-1,2-dihydroquinoline CB2 receptor inverse agonists.
41 Riikonen R et al. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism.
42 Saario SM et al. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.
43 Suomalaisen Lääkäriseuran Duodecimin, ja Päihdelääketieteen yhdistyksen asettama työryhmä. Huumeongelmaisen hoito. Käypä hoito -suositus.
44 Turpeinen M et al. Cytochrome P450 (CYP) inhibition screening: Comparison of three tests.
45 Turpeinen M et al. The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.
46 Vanamo K et al. Video-assisted thoracoscopic versus open surgery for persistent ductus arteriosus.
47 Venäläinen JI et al. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors.
48 Vähäkangas K, Länsimies E. Terveiden koehenkilöiden tutkimisen eettisiä ongelmia.
49 Vähäkangas K, Myllynen P. Experimental methods to study human transplacental exposure to genotoxic agents.
50 Yegani M et al. Effects of feeding grains naturally contaminated with Fusarium mycotoxins on brain regional neurochemistry of laying hens, turkey poults, and broiler breeder hens.

Farmakologian ja toksikologian laitos Department of Pharmacology and Toxicology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008